![]() Lurtotecan structure
|
Common Name | Lurtotecan | ||
---|---|---|---|---|
CAS Number | 149882-10-0 | Molecular Weight | 518.56100 | |
Density | 1.5g/cm3 | Boiling Point | 844.8ºC at 760mmHg | |
Molecular Formula | C28H30N4O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 464.7ºC |
Use of LurtotecanLurtotecan (GI147211; OSI-211), a semisynthetic Camptothecin analog, is a topoisomerase I inhibitor. Lurtotecan has anticancer effects[1]. |
Name | Lurtotecan |
---|---|
Synonym | More Synonyms |
Description | Lurtotecan (GI147211; OSI-211), a semisynthetic Camptothecin analog, is a topoisomerase I inhibitor. Lurtotecan has anticancer effects[1]. |
---|---|
Related Catalog | |
Target |
Topoisomerase I |
References |
Density | 1.5g/cm3 |
---|---|
Boiling Point | 844.8ºC at 760mmHg |
Molecular Formula | C28H30N4O6 |
Molecular Weight | 518.56100 |
Flash Point | 464.7ºC |
Exact Mass | 518.21700 |
PSA | 106.36000 |
LogP | 1.47400 |
Vapour Pressure | 2.51E-30mmHg at 25°C |
Index of Refraction | 1.73 |
Storage condition | -20°C |
GG 211 |
11H-1,4-Dioxino(2,3-g)pyrano(3',4':6,7)indolizino(1,2-b)quinoline-9,12(8H,14H)-dione,8-ethyl-2,3-dihydro-8-hydroxy-15-((4-methyl-1-piperazinyl)methyl)-,(8S) |
NX 211 |
(7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin) |
OSI-211 |
7-[(4-methylpiperazino)methyl]-10,11-(ethylenedioxy)-(20S)-camptothecin |